Official, Scientist In AID Malaria Program Face Trial

WASHINGTON--For entomologist James Erickson, the former director of the U.S. Agency for International Development's troubled malarial vaccine program (The Scientist, July 10, 1989, page 1, and Dec. 11, 1989, page 1), 1989 was not a good year. And this week he'll find out whether things are going to get any better in 1990. Erickson goes before U.S. District Court in Alexandria, Va., to defend himself against charges that he defrauded the government program of more than $140,000. He was indicted

Written byJim Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON--For entomologist James Erickson, the former director of the U.S. Agency for International Development's troubled malarial vaccine program (The Scientist, July 10, 1989, page 1, and Dec. 11, 1989, page 1), 1989 was not a good year. And this week he'll find out whether things are going to get any better in 1990.

Erickson goes before U.S. District Court in Alexandria, Va., to defend himself against charges that he defrauded the government program of more than $140,000. He was indicted last fall on 14 criminal counts after an investigation by the agency's inspector general's office. With him in the dock will be Wasim Siddiqui, a microbiologist from the University of Hawaii charged separately with defrauding the agency of $134,000 in connection with a series of grants he received (The Scientist, Oct. 16, 1989, page 8).

Both men are expected to argue that they are being punished for complaining to Congress ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies